Merck (MRK) is one of the brightest stars in the pharmaceutical industry with an overflowing pipeline of twenty new drugs in phase III clinical trials. The new drugs cover a host of troubling ailments, including everything from insomnia and allergies to osteoporosis and HIV. Merck is expecting bountiful returns on its research and should be raking in [...]

AT&T (T) is a communications giant with a powerful array of network resources that include the nation’s largest 4G network. Although the company recently declared a quarterly dividend of $0.44 a share, its shareholders have had it pretty rough over the past few years. If revenue is not falling, Verizon (VZ) is having a shot at AT&T’s customers. [...]

One time market darling, Netflix (NFLX), released its Q3 earnings report after the market close on Tuesday. Analysts expected it to report 5 cents per share on revenue of $904.4 million. Despite beating both of those estimates with earnings of 13 cents per share and $905.1 million in revenue, Netflix took a tumble after hours due to lower than expected [...]

JPMorgan’s (JPM) recent third quarter earnings has given financial investors something to cheer about. The investment banking giant was estimated to release earnings of $1.22 on revenue of $24.3 billion by analysts. Instead, JPMorgan reported earnings of $1.40 on revenue of $25.1 billion. This third quarter earnings beat was a huge sigh of relief for the [...]